Morphic Holding Inc

Morphic Holding Inc Stock Forecast & Price Prediction

Live Morphic Holding Inc Stock (MORF) Price
$37.68

0

Ratings

  • Buy 0
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$37.68

P/E Ratio

-24.32

Volume Traded Today

$394,400

Dividend

Dividends not available for MORF

52 Week High/low

63.08/19.35

Morphic Holding Inc Market Cap

$1.87B

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $MORF ๐Ÿ›‘

Before you buy MORF you'll want to see this list of ten stocks that have huge potential. Want to see if MORF made the cut? Enter your email below

MORF Summary

From what 0 stock analysts predict, the share price for Morphic Holding Inc (MORF) might decrease by 100% in the next year. This is based on a 12-month average estimation for MORF. Price targets go from $ to $. The majority of stock analysts believe MORF is a sell. Please note analyst price targets are not guaranteed and could be missed completely.

MORF Analyst Ratings

Morphic Holding Inc has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating, the expectation is that Morphic Holding Inc will perform worse than the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.

MORF stock forecast by analyst

These are the latest 20 analyst ratings of MORF.

Analyst/Firm

Rating

Price Target

Change

Date

Data Not Found!

MORF Company Information

Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer. Its lead product candidate MORF-057, an a4รŸ7-specific integrin inhibitor affecting inflammation is in Phase 2 clinical trials for the treatment of inflammatory bowel disease. The company's products in pipeline include Next Gen a4รŸ7 Inhibitors for additional potential GI indications, such as EGIDs, pouchitis, etc.; avรŸ8 for the treatment of Myelofibrosis and solid tumor; and fibronectin integrin for pulmonary hypertensive. In addition, it has a license agreement with Janssen to discover and develop novel integrin therapeutics; collaboration agreement with Schrรถdinger for integrin targets; and license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
MORF
Morphic Holding Inc (MORF)

When did it IPO

2019

Staff Count

115

Country

United States

Sector/Industry

Healthcare/Biotechnology

CEO

Dr. Praveen P. Tipirneni M.D.

Market Cap

$1.87B

Morphic Holding Inc (MORF) Financial Data

In 2023, MORF generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that MORF's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

N/A

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year

Revenue From 2023

N/A

0.00 %
From Previous Year
  • Revenue TTM $6.7M
  • Operating Margin TTM -2,341.3%
  • Gross profit TTM $0
  • Return on assets TTM -17.2%
  • Return on equity TTM -24.9%
  • Profit Margin 0.0%
  • Book Value Per Share 14.54%
  • Market capitalisation $1.87B
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • Revenue for 2023 N/A
  • EPS this year (TTM) $-3.29

Morphic Holding Inc (MORF) Latest News

No news data available.

...

MORF Frequently asked questions

The highest forecasted price for MORF is $ from at .

The lowest forecasted price for MORF is $ from from

The MORF analyst ratings consensus are 0 buy ratings, 0 hold ratings, and 0 sell ratings.